The brief
For the first time, the Australian-led trial has found evidence that an experimental drug could lessen inflammation in the brains of people at high risk of Parkinson’s, potentially slowing or even stopping its development. Key points and original sources are listed below.
- For the first time, the Australian-led trial has found evidence that an experimental drug could lessen inflammation in the brains of people at high risk of Parkinson’s, potentially slowing or even stopping its development.S1S2
